Avoro Capital Advisors LLC Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$1.7T
Holdings
35
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —IMMUNOMEDICS INC | 17,714,461 | $252.8B | 15.11% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 4,798,101 | $203.5B | 12.17% | |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 1,275,000 | $139.1B | 8.32% | |
| 4 | ASNDASCENDIS PHARMA | 1,980,000 | $124.0B | 7.42% | |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,360,000 | $115.8B | 6.92% | |
| 6 | AM6AMICUS THERAPEUTICS INC | 10,125,000 | $97.0B | 5.80% | |
| 7 | IOVAIOVANCE BIOTHERAPEUTICS INC | 10,261,039 | $90.8B | 5.43% | |
| 8 | —HORIZON PHARMA PLC | 4,350,000 | $85.0B | 5.08% | |
| 9 | ARGXARGENX SE | 860,000 | $82.6B | 4.94% | |
| 10 | AMRNAMARIN CORP PLC | 5,575,000 | $75.9B | 4.54% | |
| 11 | —ZOGENIX INC | 1,975,000 | $72.0B | 4.30% | |
| 12 | —LOXO ONCOLOGY INC | 325,000 | $45.5B | 2.72% | |
| 13 | 1T7TRICIDA INC | 1,750,000 | $41.3B | 2.47% | |
| 14 | ALLOALLOGENE THERAPEUTICS INC | 1,128,584 | $27.8B | 1.66% | |
| 15 | MDGLMADRIGAL PHARMACEUTICALS INC | 225,000 | $25.4B | 1.52% | |
| 16 | ASMBASSEMBLY BIOSCIENCES INC | 1,000,000 | $22.6B | 1.35% | |
| 17 | TGTXTG THERAPEUTICS INC | 4,750,000 | $19.5B | 1.16% | |
| 18 | —INTEC PHARMA LTD | 2,500,000 | $18.9B | 1.13% | |
| 19 | —BIODELIVERY SCIENCES INTL | 4,725,000 | $17.5B | 1.05% | |
| 20 | PCRXPACIRA PHARMACEUTICALS INC | 400,000 | $17.2B | 1.03% | |
| 21 | XENEXENON PHARMACEUTICALS INC | 2,400,000 | $15.1B | 0.91% | |
| 22 | GBTUSDGLOBAL BLOOD THERAPEUTICS INC | 350,000 | $14.4B | 0.86% | |
| 23 | PTCTPTC THERAPEUTICS INC | 380,000 | $13.0B | 0.78% | |
| 24 | ESTAESTABLISHMENT LABS HOLDINGS INC | 475,000 | $13.0B | 0.78% | |
| 25 | —TELIGENT INC | 5,300,000 | $7.3B | 0.43% | |
| 26 | FRXFENNEC PHARMACEUTICALS INC | 1,105,999 | $7.1B | 0.42% | |
| 27 | KODKODIAK SCIENCES INC | 902,200 | $6.4B | 0.38% | |
| 28 | YMABUSDY MABS THERAPEUTICS INC | 310,000 | $6.3B | 0.38% | |
| 29 | —ALIMERA SCIENCES INC | 6,240,000 | $4.5B | 0.27% | |
| 30 | —PROTEOSTASIS THERAPEUTICS INC | 1,300,000 | $4.2B | 0.25% | |
| 31 | —ACER THERAPEUTICS INC | 150,000 | $3.0B | 0.18% | |
| 32 | —PERNIX THERAPEUTICS HOLDINGS INC | 6,000,000 | $2.5B | 0.15% | |
| 33 | XBISPDR SERIES TRUST - S&P BIOTECH | 500,000 | $1.4B | 0.09% | Call |
| 34 | —OUTLOOK THERAPEUTICS INC | 680,000 | $340.0M | 0.02% | |
| 35 | NBIXNEUROCRINE BIOSCIENCES INC | 50,000 | $15.0M | 0.00% | Call |